丹麦诺沃·诺迪斯克制药公司将美国付现金的糖尿病患者的Ozempic价格降至每月499美元。 Danish drug firm Novo Nordisk cuts Ozempic price to $499 monthly for U.S. cash-paying diabetics.

丹麦Novo Nordisk制药公司现在向美国支付现金的病人提供其糖尿病药物Ozempic,每月499美元。 Danish drug company Novo Nordisk is now offering its diabetes medication Ozempic for $499 per month to U.S. patients paying with cash. 这项举措是该公司为改善获得服务情况所作努力的一部分,通过NovoCare提供。 NovoCare是今年早些时候启动的一个药房方案。 This move, part of the company's efforts to improve access, is available through NovoCare, a pharmacy program launched earlier this year. Novo Nordisk正与远程保健服务公司GoodRx合作,向没有保险的病人直接提供这种药物。 Novo Nordisk is partnering with telehealth service GoodRx to provide the drug directly to patients without insurance coverage.